Navigation Links
IMPAC Medical Systems and Aperio to Develop Integrated Solution for Anatomic Pathology
Date:3/3/2008

Anatomic Pathology LIS Interface to Digital Pathology Information

Management Software

SUNNYVALE and VISTA, Calif., March 3 /PRNewswire/ -- IMPAC Medical Systems, Inc. (IMPAC), an Elekta company and leading provider of information technology solutions for anatomic pathology (AP) laboratories, and Aperio Technologies, (Aperio) a global leader in digital pathology for the healthcare and life sciences industry, announce the development of an interface between PowerPath(R), IMPAC's AP laboratory information system (LIS), and Spectrum(TM), Aperio's digital pathology information management system. The interface, now in development at both companies, is designed to optimize workflow and facilitate access of digital slide images and case data between the two systems.

"Interfacing with PowerPath addresses the demands expressed by many of our customers regarding the seamless integration of our Spectrum image management (PACS) software, which includes the ability to run our FDA-cleared IHC solutions, with a leading LIS," says Dirk Soenksen, CEO of Aperio. "We are very pleased to be working with IMPAC in delivering an integrated solution to the pathology laboratory."

"It is clear that whole slide scanning and the viewing, analysis and management of digital slide images are important developments in anatomic pathology, and we recognize these represent the beginning of a new era in process flow and data management," says George Rugg, SVP and General Manager of IMPAC's LIS business unit. "As a leading provider of anatomic pathology LIS solutions, IMPAC is excited to be working with Aperio to provide this solution to the AP community. It reinforces our commitment to integrate proven new technologies with PowerPath."

Demonstrations and full details regarding the PowerPath-Spectrum interface will be available at the United States and Canadian Academy of Pathologists (USCAP) meeting in Denver, Colorado, March 3-5. For additional information, visit IMPAC Medical Systems at booth # 612 or Aperio at booth # 122.

About IMPAC Medical Systems, Inc.

IMPAC Medical Systems provides healthcare IT solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC's open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best- of-breed systems for anatomic pathology, clinical laboratory and cancer registry. With products that range from diagnosis and treatment through long- term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency, and quality patient care.

IMPAC is part of the Elekta Group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight cancer and brain disorders.

With more than 2,000 employees globally, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information can be found at http://www.impac.com and http://www.elekta.com.

About Aperio

Aperio is digitizing pathology. We provide systems and services for digital pathology, which is an environment for the management and interpretation of pathology information that originates with the digitization of a glass slide. Aperio's award-winning ScanScope(R) slide scanning systems and Spectrum(TM) digital pathology information management software improve the efficiency and quality of pathology services for pathologists and other professionals. Applications include education, remote viewing, archival and retrieval, basic research, and image analysis. Aperio's products are FDA cleared for specific clinical applications, and are intended for research and education use for other applications. For more information, please visit http://www.aperio.com.


'/>"/>
SOURCE IMPAC Medical Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nanotechs health, environmental impacts worry scientists and the public
2. ProCure Selects IMPAC as Provider of Oncology Information Systems
3. International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact
4. IMPAC Medical Systems to Offer Revenue Cycle Inc.s Array of Oncology Products and Services to Customers
5. ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests
6. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
7. Landfill mining reduces environmental impact of growing waste
8. Landfill mining reduces environmental impact of growing waste
9. Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
10. M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
11. Renowned Radiologist Peter J. Julien, MD Named Radlink Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)...  VWR Corporation (NASDAQ: VWR), the leading global independent provider ... today reported its financial results for the fourth quarter and ... 4Q16 record quarterly net sales of $1.13 ... basis. 4Q16 EMEA-APAC segment net ... the Americas net sales increased 2.5%, or down 0.9% on ...
(Date:2/23/2017)... SAN RAFAEL, Calif., Feb. 23, 2017 ... of U.S. dollars, except per share data, unaudited)Three Months ... ChangeTotal BioMarin Revenue $ ...     22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... 23, 2017  MIODx announced today that it ... immunotherapy technologies from the University of California, San ... to monitor a patient for response to immune ... The second license extends the technology with a ... to have an immune-related adverse event (IRAE) from ...
(Date:2/23/2017)... Feb. 23, 2017  Imanis Life Sciences announced ... of oncolytic vaccinia viruses for virotherapy research. These ... of Genelux,s proprietary, vaccinia virus-based technology platform for ... enter into a partnership with Genelux to offer ... viruses for use in research," said Dr. ...
Breaking Biology Technology:
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
(Date:1/30/2017)... 30, 2017   Invitae Corporation (NYSE: ... information companies, today announced that it will report its ... 2017 guidance on Monday, February 13, 2017, and Invitae,s ... at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... briefly review financial results, guidance, and recent developments and ...
(Date:1/24/2017)... Jan. 24, 2017  It sounds simple and ... that monitors vital signs and alerts parents on ... oxygen saturation level drops. But pediatric experts argue ... parents, with no evidence of medical benefits, especially ... marketed aggressively to parents of healthy babies, promising ...
Breaking Biology News(10 mins):